NL8104482A - Aminoalkylfuranderivaat; werkwijze voor het bereiden daarvan; farmaceutisch preparaat. - Google Patents

Aminoalkylfuranderivaat; werkwijze voor het bereiden daarvan; farmaceutisch preparaat. Download PDF

Info

Publication number
NL8104482A
NL8104482A NL8104482A NL8104482A NL8104482A NL 8104482 A NL8104482 A NL 8104482A NL 8104482 A NL8104482 A NL 8104482A NL 8104482 A NL8104482 A NL 8104482A NL 8104482 A NL8104482 A NL 8104482A
Authority
NL
Netherlands
Prior art keywords
ranitidine hydrochloride
ranitidine
hydrochloride
solution
3vwd
Prior art date
Application number
NL8104482A
Other languages
English (en)
Dutch (nl)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10516407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL8104482(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NL8104482A publication Critical patent/NL8104482A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NL8104482A 1980-10-01 1981-10-01 Aminoalkylfuranderivaat; werkwijze voor het bereiden daarvan; farmaceutisch preparaat. NL8104482A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8031634 1980-10-01
GB8031634 1980-10-01

Publications (1)

Publication Number Publication Date
NL8104482A true NL8104482A (nl) 1982-05-03

Family

ID=10516407

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8104482A NL8104482A (nl) 1980-10-01 1981-10-01 Aminoalkylfuranderivaat; werkwijze voor het bereiden daarvan; farmaceutisch preparaat.

Country Status (29)

Country Link
US (2) US4521431A (xx)
JP (1) JPS5791983A (xx)
KR (1) KR870001431B1 (xx)
AT (1) AT389696B (xx)
AU (1) AU549119B2 (xx)
BE (1) BE890574A (xx)
CA (1) CA1202638A (xx)
CH (1) CH652122A5 (xx)
CZ (1) CZ280885B6 (xx)
DE (1) DE3139134A1 (xx)
DK (2) DK167794B1 (xx)
ES (1) ES8301954A1 (xx)
FR (1) FR2491067A1 (xx)
GR (1) GR72499B (xx)
HK (1) HK97985A (xx)
IE (1) IE51604B1 (xx)
IL (1) IL63968A (xx)
IT (1) IT1143237B (xx)
KE (1) KE3549A (xx)
LU (1) LU83661A1 (xx)
MY (1) MY8500747A (xx)
NL (1) NL8104482A (xx)
NZ (1) NZ198522A (xx)
PH (2) PH19489A (xx)
PT (1) PT73744B (xx)
SE (1) SE453500B (xx)
SK (1) SK403591A3 (xx)
ZA (1) ZA816809B (xx)
ZW (1) ZW24481A1 (xx)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK162525C (da) * 1983-07-15 1992-03-30 Richter Gedeon Vegyeszet Fremgangsmaade til fremstilling af ranitidin-hydroklorid
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
CN1048984C (zh) * 1991-12-20 2000-02-02 多坎化学有限公司 晶形1呋喃硝胺氢氯化物的制备
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
ES2157254T3 (es) * 1993-03-12 2001-08-16 Upjohn Co Ceftiofur (acido libre) cristalino.
DE4341310A1 (de) * 1993-12-03 1995-06-08 Hexal Pharma Gmbh Tablette oder Kapsel mit einem Gehalt an stabilem Ranitidinhydrochlorid Form 1
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
EP0754182A1 (en) * 1994-04-08 1997-01-22 Brantford Chemicals Inc. Form 1 ranitidine hydrochloride with increased density
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
US6452007B1 (en) 1994-04-15 2002-09-17 Pharmacia & Upjohn Company Crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine
NZ272054A (en) * 1994-05-13 1996-05-28 Ranbaxy Lab Ltd Process for producing form 1 ranitidine hydrochloride
IN181699B (xx) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
IN181698B (xx) * 1994-05-13 1998-09-05 Ranbaxy Lab Ltd
DE69527429T2 (de) * 1994-05-18 2003-03-20 Aventis Pharma Inc Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
DE69504156T2 (de) 1994-06-24 1998-12-24 Ranbaxy Lab Ltd Verfahren zur Herstellung von Ranitidinhydrochlorid in der Kristallform 1
MX9703622A (es) * 1994-11-18 1997-08-30 Upjohn Co Una nueva forma solida fisicamente estable en una fluoroquinolona.
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5663381A (en) * 1995-04-21 1997-09-02 Hexal Pharmaceuticals, Inc. Process for preparing form 1 ranitidine hydrochloride
US5686588A (en) * 1995-08-16 1997-11-11 Yoo; Seo Hong Amine acid salt compounds and process for the production thereof
AU1972097A (en) * 1996-03-25 1997-10-17 Hoechst Marion Roussel, Inc. Process for the preparation of form 1 ranitidine hydrochloride
EP0987256B1 (de) 1997-08-08 2001-10-17 Aventis Pharma Deutschland GmbH Kristallform von N-(4-Trifluormethylphenyl)-5-methylisoxazol-4-carbonsäureamid
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
IT1317858B1 (it) * 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
US6569887B2 (en) * 2001-08-24 2003-05-27 Dov Pharmaceuticals Inc. (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
US20060173064A1 (en) * 2001-08-24 2006-08-03 Lippa Arnold S (-)-1-(3,4-Dichlorophenyl)-3-azabi cyclo[3.1.0]hexane, compositions thereof, and uses for treating alcohol-related disorders
US7235655B2 (en) * 2002-03-22 2007-06-26 Pharmacia & Upjohn Company Processes to prepare eplerenone
TW200409746A (en) * 2002-07-26 2004-06-16 Theravance Inc Crystalline β2 adrenergic receptor agonist
US20080081834A1 (en) 2002-07-31 2008-04-03 Lippa Arnold S Methods and compositions employing bicifadine for treating disability or functional impairment associated with acute pain, chronic pain, or neuropathic disorders
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
RU2005117630A (ru) * 2002-11-08 2006-01-20 Дов Фармасьютикал, Инк. (Us) Полиморфы гидрохлорида бицифадина
TW200510277A (en) * 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist
US7384557B2 (en) * 2003-07-14 2008-06-10 Applied Ambient Extraction Process Consultants, Llc Method and apparatus for removing solute from a solid solute-bearing product
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
US20070043100A1 (en) * 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
JP5184354B2 (ja) 2005-07-27 2013-04-17 ユーシミクス バイオサイエンス，インク． 新規１−アリール−３−アザビシクロ［３．１．０］ヘキサン：調製および神経精神障害の処理への使用
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
NZ576355A (en) * 2006-10-20 2012-04-27 Scinopharm Singapore Pte Ltd Process for making crystalline anhydrous docetaxel
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
US20090069374A1 (en) * 2007-06-06 2009-03-12 Phil Skolnick Novel 1-Heteroaryl-3-Azabicyclo[3.1.0]Hexanes, Methods For Their Preparation And Their Use As Medicaments
TW201011043A (en) 2008-06-20 2010-03-16 Chugai Pharmaceutical Co Ltd Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives
EP2727912B1 (en) * 2011-06-30 2017-04-19 Toray Industries, Inc. Crystals of glycine derivative and pharmaceutical use thereof
CN106432148B (zh) * 2015-05-26 2018-04-17 烟台市华文欣欣医药科技有限公司 一种治疗胃病的药物盐酸雷尼替丁化合物的制备方法
CN105030694A (zh) * 2015-08-04 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种治疗胃溃疡的药物盐酸雷尼替丁组合物干混悬剂
CN104971053A (zh) * 2015-08-05 2015-10-14 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化系统疾病的药物盐酸雷尼替丁组合物片剂
CN105055331A (zh) * 2015-08-31 2015-11-18 青岛蓝盛洋医药生物科技有限责任公司 一种治疗消化性溃疡的药物盐酸雷尼替丁组合物颗粒剂
WO2021079183A1 (en) * 2019-10-21 2021-04-29 Sms Pharmaceuticals Limited Isopropyl alcohol solvent free crystalline ranitidine hydrochloride form-2 which is free of nitrosamine (ndma) impurity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DK436281A (da) 1982-04-02
SK277922B6 (en) 1995-08-09
SE8105812L (sv) 1982-04-02
HK97985A (en) 1985-12-13
MY8500747A (en) 1985-12-31
BE890574A (fr) 1982-04-01
US4521431A (en) 1985-06-04
ZW24481A1 (en) 1983-04-27
IL63968A0 (en) 1981-12-31
AU7595581A (en) 1982-04-08
ATA422281A (de) 1989-06-15
CH652122A5 (fr) 1985-10-31
PH19489A (en) 1986-05-14
KR830007070A (ko) 1983-10-14
PH21761A (en) 1988-02-18
PT73744B (en) 1983-10-31
NZ198522A (en) 1985-07-12
CZ403591A3 (en) 1994-01-19
GR72499B (xx) 1983-11-15
AU549119B2 (en) 1986-01-16
AT389696B (de) 1990-01-10
FR2491067A1 (fr) 1982-04-02
US4672133A (en) 1987-06-09
JPH0443070B2 (xx) 1992-07-15
KR870001431B1 (ko) 1987-08-06
LU83661A1 (fr) 1983-06-08
DE3139134A1 (de) 1982-05-19
IT8149407A0 (it) 1981-10-01
SE453500B (sv) 1988-02-08
DK167923B1 (da) 1994-01-03
IT1143237B (it) 1986-10-22
DK33792A (da) 1992-03-12
IE812287L (en) 1982-04-01
FR2491067B1 (xx) 1984-09-07
CA1202638A (en) 1986-04-01
DK167794B1 (da) 1993-12-13
DE3139134C2 (xx) 1990-04-19
IE51604B1 (en) 1987-01-21
ES505951A0 (es) 1983-01-01
DK33792D0 (da) 1992-03-12
ES8301954A1 (es) 1983-01-01
ZA816809B (en) 1983-05-25
KE3549A (en) 1985-08-16
PT73744A (en) 1981-10-01
CZ280885B6 (cs) 1996-04-17
JPS5791983A (en) 1982-06-08
IL63968A (en) 1985-10-31
SK403591A3 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
NL8104482A (nl) Aminoalkylfuranderivaat; werkwijze voor het bereiden daarvan; farmaceutisch preparaat.
US20190367458A1 (en) Crystal form of quinoline compound and process for its production
GB2084580A (en) Aminoalkyl Furan Derivative
US5700820A (en) Polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation
JPH0523269B2 (xx)
JP2000511875A (ja) 抗糖尿病活性を増強されたトログリタゾンの新規な多形型及びそれらの製造方法
DE3786109T2 (de) Pyrido[2,3-d]pyrimidin-Derivate.
SU1240363A3 (ru) Способ получени ( @ )-5-(2-бромвинил)уридина
US5663381A (en) Process for preparing form 1 ranitidine hydrochloride
HU192799B (en) Process for producing rolling cristalline cristalline oxytetracycline-hydrochloride
CA2074833A1 (fr) Derives d'(alkylthio-3 propyl)-3 benzothiazoline, leur preparation et les medicaments les contenant
JP2566843B2 (ja) ベンゾチアジン誘導体、その製法、及び医薬品として又は医薬品の合成中間体としてのその適用
IE902437A1 (en) 6- and 7-Deoxyforskolin and derivatives thereof,¹intermediates and a process for their preparation and their¹use as medicaments
EP0044705B1 (en) Substituted pyrimidin-2-ones, the salts thereof, processes for their preparation, pharmaceutical compositions containing them and a method therefor
Baker et al. 6-Methoxy-8-nitroquinolines with Substituents in the 3-and 4-Positions
Dyachenko et al. Multicomponent Synthesis and Molecular and Crystal Structure of New Derivatives of Partially Hydrogenated Quinolines
JPS5829766A (ja) カルボスチリル誘導体
PT92823A (pt) Processo para a preparacao de eteres 7-arilicos e hetero-arilicos de desacetil--forscolina e de composicoes farmaceuticas que os contem
NL7908189A (nl) Nieuwe perhydrothiazine-1.3-derivaten, de bereiding ervan, alsmede geneesmiddelen die de nieuwe derivaten bevatten.
US2479148A (en) S-crotyl-s-phenylbarbituric
AU2013204129B2 (en) Crystal Form of Quinoline Compound and Process for its Production
Masucci et al. Biochemical Studies of Bacterial Derivatives: XIII. The Occurrence of Mannose and d-Arabinose in the Polysaccharide Isolated from the Filtrate of Human Tubercle-Bacillus Cultures
HU191091B (en) Process for the production of the polymorphic formations of the 5-/3-/2-/2,2,2-trifluor-ethyl/-guanidino/-pirazol-1-il/-valeramide
Hiller et al. Analogs of pyrimidine nucleosides: IV. The silyl method of obtaining N1-(α-tetrahydrofuryl) and N1-(α-tetrahydropyranyl) derivatives of uracils and 6-azauracil
JPS62258384A (ja) ペネム化合物の結晶質一水和物及びその製造方法

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable